Clinical Trial Update: Evaluation of Remnant Liver Function Using Primovist-enhanced MRI Before Resection/Ablation of Hepatocellular Carcinoma

View source ↗

Summary

This completed clinical trial evaluated remnant liver function using Primovist-enhanced MRI before resection or ablation of hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Dysfunction

Drugs mentioned

• Primovist (Gadoxetate disodium)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Carcinoma, Hepatocellular, Liver Dysfunction | Status: COMPLETED